Scientists highlight new insights into triple-negative breast cancer
November 30, 2022 -- Boston University researchers have demonstrated that control of a certain cellular pathway can prevent the development of triple-negative breast cancer, which they contend could help identify new therapeutic options. Read More
Increasing immune cell production may reverse cognitive decline: study
November 30, 2022 -- Rutgers University researchers have discovered that the underproduction of immune cells called mucosal-associated invariant T cells contribute to Alzheimer’s disease and other cognitive disorders. Their study, published November 21 in the journal Nature Immunology, shows how increasing these cells could reverse the damage. Read More
Rogue killer T cells contribute to autoimmunity: study
November 29, 2022 -- Scientists from the Garvan Institute of Medical Research have found new insight into the role that killer T cells play in leukemia and autoimmune disease. They contend that their findings could be helpful in narrowing down pathways to target these cells for future treatments. Read More
Novel nanoparticles deliver cancer therapy
November 29, 2022 -- University of Pittsburgh researchers have designed cancer-fighting nanoparticles that co-deliver an existing chemotherapy drug along with a novel immunotherapy that silences an immunosuppression gene. Read More
Tankyrase holds potential for bowel cancer drug development: study
November 29, 2022 -- Scientists from the Institute of Cancer Research, London have discovered the inner workings of a protein called tankyrase, which plays a key role in driving bowel cancer. The researchers contend that their findings could open the door for better and less toxic cancer drugs. Read More
Drug to treat prostate cancer shows promise
November 28, 2022 -- A single drug compound attacks prostate cancer by triggering immune cells and hinders the tumor's ability to use testosterone as fuel, a new study finds. The drug could be used to treat other solid tumors that don't respond to standard therapy. Read More
Certain protein creates domino effect to set off ALS
November 28, 2022 -- King's College London researchers have found that the loss of a processing protein is likely the molecular trigger in the neurodegenerative disorder amyotrophic lateral sclerosis (ALS). Read More
'Immunologic memory' may explain chronic inflammation in HIV: study
November 23, 2022 -- A study by researchers from George Washington University may explain why chronic inflammation occurs in people living with HIV and how suppression or even eradication of the virus may not resolve it. Read More
Tumor matrix profiling may help lung cancer patients
November 22, 2022 -- Garvan Institute scientists have identified molecular profiles of the matrix surrounding common lung cancers that may indicate which patients are likely to develop aggressive tumors. Read More
Unusual antibody proves potent against Zika virus
November 21, 2022 -- Researchers have identified an unusual type of antibody that, even at miniscule levels, neutralizes the Zika virus rendering viral infection undetectable in preclinical models. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
